A novel imaging agent can reduce the number of false-positive PET/CT findings among cancer patients recently vaccinated for Covid-19. This may mitigate the issue of tracer uptake in lymph nodes associaed with the vaccine.
In men recently diagnosed with intermediate or high-grade prostate cancer, PSMA PET/MRI can successfully determine whether their cancer is likely to return within two years of a prostatectomy.
AI-based models for multimodality hybrid imaging have the potential to be a potent clinical tool but are currently held back by a lack of transparency and maturity, says Dr Irène Buvat, from the Laboratory of translational Imaging in Oncology, Institute Curie in Paris, France.
Researchers from the University of Jyväskylä and the Central Finland Health Care District have developed an AI based neural network to detect an early knee osteoarthritis from x-ray images.
Medical imaging and healthcare IT company Esaote reports that it has completed the transition of its medical devices to comply with the new Medical Device Regulation (MDR).
Dutch scientists have performed whole-body PET scans using a radioactively labeled antibody tracer against immune cells, to predict the effect of treatment with immune checkpoint inhibitors.
A promising new application for photon-counting CT: The new technology outperforms conventional CT in detecting subtle damage in the lungs of patients with persistent symptoms of Covid-19.
Multiparametric ultrasound will play an increasing role in imaging investigation and diagnosis as more subspecialities reap the benefits from the modality, Professor Paul Sidhu believes. The leading expert predicts that it will be more cost-effective and comfortable for patients and take point-of-care-testing onto a new level by embracing other parameters in the imaging process.
Tapping the thriving Radiology AI ecosystem, Bayer recently announced three collaboration agreements for its digital platform, Calantic Digital Solutions, as well as an AI accelerator program.
OpenRad announced at RSNA the launch of its enterprise remote reporting platform, which enables cloud-based reporting, collaborative workflows across companies and advanced mobile fleet management.
At the annual RSNA meeting in Chicago, Carestream launched a new series of digital X-ray detectors to help improve clinical outcomes, as well as enhancements to its existing product portfolio.
Using fluorodeoxyglucose positron emission tomography (FDG-PET) imaging may give insights into possible dose reductions in ongoing radiation therapy of head and neck cancer. A promising study to explore this option was presented at the 2022 ASTRO/ASCO Multidisciplinary Head and Cancer Symposium held in Phoenix, Arizona.
The need for breast cancer screening of transgender individuals has been a topic of uncertainty until recently, due to lack of reliable patient data, consensus by radiologists, published research, and recommended guidelines. A 2021 survey of Society of Breast Imaging (SBI) members revealed that ‘breast radiologists differ in their practice and knowledge regarding screening of transgender…
Radiographers could help design new artificial intelligence (AI) tools for radiation protection, Mark McEntee, professor of diagnostic radiography at University College Cork, Ireland, argued during the annual EuSoMII meeting in October.
In radiology, it is not about if but about when artificial intelligence (AI) will be used, said Professor Dr Tim Leiner of Utrecht University Medical Center at this year’s European Congress of Radiology in Vienna. For all those who are new to AI, the Dutch radiologist gave an overview of the lessons he and his team have learnt so far.
Medical imaging is critical across many fields of healthcare – but accessing it in remote or rural locations can be a struggle, resulting in missed appointments or delayed diagnoses. Fujifilm Healthcare Europe is a leading provider of medical imaging solutions across all modalities, and offers a range of portable imaging systems that allow imaging solutions to be taken closer to the patient.
For the first time, a new study has identified enlarged perivascular spaces in the brains of migraine sufferers. Results of the study will be presented at the annual RSNA meeting.
Using a special type of MRI, researchers have uncovered brain changes in patients up to six months after they recovered from Covid-19, according to a study being presented at the annual RSNA meeting.
Swiss researchers developed a new MRI method to visualise metabolic processes in the body. Their objective is to improve the future diagnosis and treatment of heart disease.
Magnetic resonance imaging (MRI) can reliably establish measurements for anterior cruciate ligament (ACL) “footprints” that are critical to the placement of grafts for reconstruction surgery.
Siemens Healthineers presented its latest magnetic resonance tomographs designed for clinical and scientific use at the company's Shape 23 Keynote: The 3T Magnetom Cima.X and 7T Magnetom Terra.X.
On March 31st, 2022, a city-wide lockdown to curtail the spread of the Covid-19 virus in Shanghai, China, shuttered the GE Healthcare manufacturing facility that produces 80% of the global supply of iodinated contrast media agents iohexol (Omnipaque) and lodixanol (Visipaque). Although the plant was able to operate at 50% capacity by mid-May, the shutdown resulted in a substantial contrast media…
Endosonography poses unique challenges for medical professionals, because two demanding disciplines have to be mastered at the same time. The use of artificial intelligence (AI) could help speed up the notoriously slow learning curve of the procedure, says Prof Dr Christoph F. Dietrich. At the Visceral Medicine Congress in Hamburg, the expert explained how AI can help endosonography achieve…
A new X-ray technology has been used to identify a link between the damage that severe Covid-19 can inflict on lungs and pulmonary fibrosis, a disease that causes severe scarring of lung tissue.
White matter hyperintensities (WMH) on the brain seen on MRI represent a biomarker associated with a 50/50 risk of death within five years after a first incident acute ischemic stroke (AIS) or transient ischemic attack (TIA).